C4 Therapeutics Inc. Gains 98.31%
Tue, Dec 12, 2023 at 07:15 PM
C4 Therapeutics Inc. (CCCC:NASDAQ) jumped higher at $2.34, a gain of 98.3%. On Tue, Dec 12, 2023, CCCC:NASDAQ touched a New 2-Week High of $2.34. The stock got featured on our News Catalysts scanner on Tue, Dec 12, 2023 at 05:55 PM in the 'BIOTECH' category. From Tue, Nov 28, 2023, the stock recorded 40.00% Up Days and 36.36% Green Days
About C4 Therapeutics Inc. (CCCC:NASDAQ)
C4 Therapeutics Inc is a bio-pharmaceutical company.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 150%
- C4 Therapeutics Inc. (CCCC:NASDAQ), 98.31%
- Vinco Ventures Inc. (BBIG:NASDAQ), 66.67%
- Kubient Inc. (KBNT:NASDAQ), 62.5%
- Aditxt Inc. (ADTX:NASDAQ), 60.26%
- Icosavax Inc. (ICVX:NASDAQ), 49.48%
- Chanson International Holding (CHSN:NASDAQ), 36.56%
- Evofem Biosciences, Inc. (EVFM:NASDAQ), 35.71%
- Hanryu Holdings, Inc. (HRYU:NASDAQ), 35.05%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 34%